- The multi-year strategic partnership will enable GenesisCare to offer patients greater access to leading technology, with a plan to explore further collaborations to improve cancer diagnosis, treatment and cardiovascular care
- The agreement is valued at more than USD 130 million over the next five years, including imaging technologies, digital solutions, clinical education and services
- Together, GenesisCare and GE Healthcare aim to achieve earlier, faster, and more confident cancer diagnosis and more precise intervention and individualized treatment, leading to better patient outcomes
San Francisco, California (UroToday.com) — GE Healthcare, the leading global provider of advanced medical imaging, and GenesisCare, a leading provider of integrated cancer care globally and cardiovascular care in Australia, announced a strategic partnership aimed at improving patient outcomes for the two biggest health burdens globally, cancer and heart disease.